Evidence map›Paper›PMID 28646905›Full record

ReviewParticle and fibre toxicology2017

Mechanistic understanding of nanoparticles' interactions with extracellular matrix: the cell and immune system.

Ayse Basak Engin, Dragana Nikitovic, Monica Neagu, Petra Henrich-Noack, Anca Oana Docea, Mikhail I Shtilman, Kirill Golokhvast, Aristidis M Tsatsakis

Abstract readReview
In one paragraph

Review in Particle and fibre toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Multiscale Construction, Evaluation, and Application of Organoids.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  10. Article
  11. Computation-aided design of rod-shaped nanoparticles for tumoral targeting.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ayse Basak EnginDepartment of Toxicology, Faculty of Pharmacy, Gazi University, Hipodrom, 06330, Ankara, Turkey.
Dragana NikitovicLaboratory of Anatomy-Histology-Embryology, Medical School, University of Crete, Heraklion, Greece.
Monica Neagu"Victor Babes" National Institute of Pathology, Immunology Department, 99-101 Splaiul Independentei, 050096, Bucharest, Romania.
Petra Henrich-NoackInstitute of Medical Psychology, Otto-von-Guericke University, 39120, Magdeburg, Germany.
Anca Oana DoceaDepartment of Toxicology, University of Medicine and Pharmacy, Faculty of Pharmacy, Petru Rares, 200349, Craiova, Romania.
Mikhail I ShtilmanMaster School Biomaterials, D.I. Mendeleyev University of Chemical Technology, Moscow, Russia.
Kirill GolokhvastScientific Educational Center Nanotechnology, Engineering School, Far Eastern Federal University, Vladivostok, Russian Federation.
Aristidis M TsatsakisScientific Educational Center Nanotechnology, Engineering School, Far Eastern Federal University, Vladivostok, Russian Federation. aris@med.uoc.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular matrix (ECM) is an extraordinarily complex and unique meshwork composed of structural proteins and glycosaminoglycans. The ECM provides essential physical scaffolding for the cellular constituents, as well as contributes to crucial biochemical signaling. Importantly, ECM is an indispensable part of all biological barriers and substantially modulates the interchange of the nanotechnology products through these barriers. The interactions of the ECM with nanoparticles (NPs) depend on the morphological characteristics of intercellular matrix and on the physical characteristics of the NPs and may be either deleterious or beneficial. Importantly, an altered expression of ECM molecules ultimately affects all biological processes including inflammation. This review critically discusses the specific behavior of NPs that are within the ECM domain, and passing through the biological barriers. Furthermore, regenerative and toxicological aspects of nanomaterials are debated in terms of the immune cells-NPs interactions.

Indexed as

AnimalsExtracellular MatrixExtracellular Matrix ProteinsHumansImmune SystemInflammationInflammation MediatorsNanoparticlesRisk AssessmentSignal TransductionExtracellular Matrix ProteinsInflammation MediatorsBiological barriersExtracellular matrixInflammationNanoparticle

Identifiers

PMID28646905
PMCPMC5483305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.